Erlotinib is a EGFR inhibitor. It’s used for NSCLC and pancreatic cancer with EGFR mutations. It works by stopping EGFR signaling.
You can get it in 25, 100, or 150 mg tablet forms. The usual dose is 150 mg a day, on an empty stomach. You’ll find it in bottles with 30 tablets each.
The tablets should be taken on an empty stomach to make sure they absorb well. You should only take Erlotinib under a doctor’s care, as it depends on your EGFR mutation and your health. There might be side effects, so talk to your doc about them.
The dose might change based on the kind of mutation and how your body reacts to the treatment.
